期刊文献+

氨体舒通对环孢素A致大鼠慢性肾毒性的改善作用 被引量:1

Protective effects of spironolactone on chronic cyclosporine A nephrotoxicity in rats
下载PDF
导出
摘要 目的:探讨氨体舒通对大鼠慢性环孢素A(CsA)肾病(CCN)的改善作用。方法:36只雄性SD大鼠在低盐饮食基础上随机分对照组、模型组、治疗组。模型组及治疗组皮下给予CsA15mg/(kg·d),治疗组同时给予氨体舒通20mg/(kg·d)灌胃。第14天和第28天每组随机处死6只大鼠,处死前入代谢笼收集24h尿,测尿肌酐及血肌酐(Scr),计算肌酐清除率(Ccr)。放免法测血浆醛固酮水平。肾脏组织标本行HE和Masson染色,检测肾组织单个核细胞浸润、肾间质纤维化及转化生长因子-β1(TGF-β1)的表达情况。结果:与对照组大鼠相比,实验第2周开始至第4周末,模型组大鼠Ccr降低,单个核细胞计数、TGF-β1明显升高,模型组大鼠血醛固酮、间质纤维化积分在第4周末明显升高;给予氨体舒通治疗后,各项指标在不同时间点均向正常方向发展。结论:醛固酮在CCN的结构和功能变化中起了重要的致纤维化作用,氨体舒通通过抑制肾组织中TGF-β1表达和肾小管间质炎症细胞的浸润,对CCN起到改善作用。 Aim: To evaluate the protective effects of spironolactone on chronic CsA nephrotoxicity(CCN). Methods: Thirty-six adult male SD rats were allocated into control group, model group, spironolactone group at random. With lowersalt diet, model group and spironolactone group was given CsA at 15 mg/( kg · d) , meanwhile, spironolactone was given to rats in spironolactone group. At the end of 2 and 4 weeks, 6 rats of each group were sacrificed. Serum and urine creatinine were determined. Creatinine clearance rate(Ccr) was calculated. The level of blood aldosterone was determined by radioimmunoassay. HE and Masson staining was performed. TGF-β1 was determined by immunohistochemical method. Results: The level of blood aldosterone was increased(P 〈 0.05). Compared with control group, the level of Ccr decreased, the infiltrated mononuclear cells in the interstitial, the degree of tubulointerstitial fibrosis and the level of TGF-β1 and aldosterone increased (P 〈 0.05). These lesions were significantly ameliorated by spironolactone ( P 〈 0.05 ). CoNclusioN : Aldosterone plays an important role in structural and function changes during CCN. Spironolactone could improve those lesions during CCN by reducing the overexpression of TGF-β1 and infiltration of mononuclear cells in the interstitial.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第6期1057-1061,共5页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目0324410084 河南省杰出青年基金资助项目74100510006
关键词 醛固酮 氨体舒通 肾小管间质纤维化 转化生长因子-Β1 大鼠 aldosterone spironolactone tubulointerstitium fibrosis TGF-β1 rat
  • 相关文献

参考文献16

  • 1Danoviteh GM. Immunosuppressive medications for renal transplantation: a multiple choice question[J ]. Kidney Int, 2001, 59(1):388.
  • 2Burodmann EA, Andoh IF, Yu L, et al. Cyelosporine nephortoxieity [ J ]. Semin Nephrol, 2003, 23 ( 5 ) :465.
  • 3Yang CW, Ahn HJ, Kim WY, et al. Synerginstic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy [ J ]. Kidney Int, 2003,75 ( 3 ) : 309.
  • 4Olyaei AJ, de Mattos AM, Bennett WM. A practical guide to the management of hypertension in renal transplant recipients[J]. Drugs, 1999, 58(6) :1011.
  • 5de Vries AP, Bakker S J, Van Son W J, et al. Insulin resistance as putative cause of chronic renal transplant dysfunction[ J]. Am J Kidney Dis, 2003,41 (4) :859.
  • 6Shihab FS,Andoh TF,Tanner AM, et al. Sodium depletion enhances fibrosis and expression of TGF-β1 and matrix proteins in experimental chronic cyclosporine nephropathy. Am J Kidney Dis,1997,30(1):71.
  • 7王沛,刘章锁,骆红,马瑨.长期应用环孢素A致大鼠肾脏病变演变过程观察[J].郑州大学学报(医学版),2007,42(6):1044-1048. 被引量:7
  • 8Feria I, Pichardo I, Juarez P, et al. Thetapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity[ J]. Kidney Int, 2003,63(1 ) :43.
  • 9Campistol JM, Sacks SH. Mechanisms of nephrotoxicity [ J ]. Transplantation, 2000,69 ( 12 Suppl ) : SS5.
  • 10Eddy AA. Molecular basis of renal fibrosis [ J ]. Pediatr Nephrol, 2000,15 ( 3/4 ) : 290.

二级参考文献25

  • 1程枫,赵涵芳,章有章,冯世杰,密磊,史济湘.大鼠浅Ⅱ度烧伤渗液细胞原位杂交生长因子mRNA表达[J].上海交通大学学报(医学版),1997,22(S1):10-12. 被引量:5
  • 2李寒,王沛,刘章锁.IgA肾病高血压发生的影响因素分析[J].郑州大学学报(医学版),2005,40(3):524-525. 被引量:7
  • 3刘章锁,王沛,程根阳,李海建,刘淑真,李继昌,刘钟明.罗格列酮对实验性慢性环孢素肾病的作用[J].中华肾脏病杂志,2007,23(4):235-241. 被引量:14
  • 4Jones HB, Clarker NA, Barrass NC. Phenobarbital-induced hepatoeellular proliferation : anti-bromodeoxyuridine and antiproliferating cell nuclear antigen immunoeytochemistry.J Histochem Cytochem, 1993,41 ( 1 ) :21.
  • 5Bennett NT, Schultz GS. Growth factors and wound healing:Biochemical properties of growth factors and their receptors.Am J Surg, 1993,165(6) :728.
  • 6Cooper DM, Yu EZ, Hennessey P, et al. Determination of endogenous cytokines in chronic wounds. Ann Surg, 1994,219(6) :688.
  • 7Whitby DJ, Ferguson MV. Immunohistochemical localization of growth factors in fatal wound healing. Develop Bio, 1991,147( 1 ) :207.
  • 8Zhang K, Garner W, Cohen L, et al. Increased type Ⅰ and Ⅲ collagen and transforming growth factor-β1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol, 1995,104(5) :750.
  • 9Brattain MG, Ko Y, Banerji SS, et al. Defects of TGF-beta receptor signaling in mammary cell tumorigenesis. J Mammary Gland Biol Neoplasia, 1996, 1 (4) :365.
  • 10McCune BK, Mullin BR, Flanders KC, et al. Localization of transforming growth factor-beta isotypes in lesions of the human breast. Hum Pathol, 1992, 23 ( 1 ): 13.

共引文献7

同被引文献23

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部